GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hanmi Science Co Ltd (XKRX:008930) » Definitions » Equity-to-Asset

Hanmi Science Co (XKRX:008930) Equity-to-Asset : 0.64 (As of Dec. 2023)


View and export this data going back to 1988. Start your Free Trial

What is Hanmi Science Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Hanmi Science Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩787,507 Mil. Hanmi Science Co's Total Assets for the quarter that ended in Dec. 2023 was ₩1,226,170 Mil. Therefore, Hanmi Science Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.64.

The historical rank and industry rank for Hanmi Science Co's Equity-to-Asset or its related term are showing as below:

XKRX:008930' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.56   Med: 0.69   Max: 0.73
Current: 0.64

During the past 13 years, the highest Equity to Asset Ratio of Hanmi Science Co was 0.73. The lowest was 0.56. And the median was 0.69.

XKRX:008930's Equity-to-Asset is ranked better than
75% of 100 companies
in the Medical Distribution industry
Industry Median: 0.385 vs XKRX:008930: 0.64

Hanmi Science Co Equity-to-Asset Historical Data

The historical data trend for Hanmi Science Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Science Co Equity-to-Asset Chart

Hanmi Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.71 0.73 0.65 0.64

Hanmi Science Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.65 0.69 0.69 0.64

Competitive Comparison of Hanmi Science Co's Equity-to-Asset

For the Medical Distribution subindustry, Hanmi Science Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanmi Science Co's Equity-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Hanmi Science Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Hanmi Science Co's Equity-to-Asset falls into.



Hanmi Science Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Hanmi Science Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=787506.951/1226170.046
=0.64

Hanmi Science Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=787506.951/1226170.046
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanmi Science Co  (XKRX:008930) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Hanmi Science Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Hanmi Science Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanmi Science Co (XKRX:008930) Business Description

Traded in Other Exchanges
N/A
Address
214 Muha-ro Paltan-myeon, Gyeonggi-do, Hwaseong, KOR
Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.

Hanmi Science Co (XKRX:008930) Headlines

No Headlines